-
Signature
-
/s/ Pamela Sergeeff, Attorney-in-fact
-
Issuer symbol
-
FRSH
-
Transactions as of
-
01 Aug 2023
-
Net transactions value
-
-$175,913
-
Form type
-
4
-
Filing time
-
03 Aug 2023, 21:21:38 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
FRSH |
Class A Common Stock |
Conversion of derivative security |
$0 |
+8,433 |
+57% |
$0.000000 |
23,357 |
03 Aug 2023 |
Direct |
|
| transaction |
FRSH |
Class A Common Stock |
Sale |
$89,351 |
-4,348 |
-19% |
$20.55 |
19,009 |
03 Aug 2023 |
Direct |
F1, F2 |
| transaction |
FRSH |
Class A Common Stock |
Sale |
$86,561 |
-4,085 |
-21% |
$21.19 |
14,924 |
03 Aug 2023 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
FRSH |
Restricted Stock Units |
Options Exercise |
$0 |
-9,370 |
-3.8% |
$0.000000 |
234,380 |
01 Aug 2023 |
Class B Common Stock |
9,370 |
|
Direct |
F4, F5 |
| transaction |
FRSH |
Class B Common Stock |
Options Exercise |
$0 |
+9,370 |
+22% |
$0.000000 |
51,114 |
01 Aug 2023 |
Class A Common Stock |
9,370 |
|
Direct |
F6 |
| transaction |
FRSH |
Class B Common Stock |
Conversion of derivative security |
$0 |
-8,433 |
-16% |
$0.000000 |
42,681 |
03 Aug 2023 |
Class A Common Stock |
8,433 |
|
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: